Published in Toxicol Appl Pharmacol on May 01, 1988
Genomics of mature and immature olfactory sensory neurons. J Comp Neurol (2012) 0.94
Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol Cell Biol (2000) 1.46
Effect of dose on the absorption and excretion of [14C]benzene administered orally or by inhalation in rats and mice. Toxicol Appl Pharmacol (1987) 1.34
Toxicology and epidemiology of 1,3-butadiene. Crit Rev Toxicol (1997) 1.26
Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem J (1990) 1.24
The effect of dose, dose rate, route of administration, and species on tissue and blood levels of benzene metabolites. Environ Health Perspect (1989) 1.15
The use of biological markers in toxicology. Crit Rev Toxicol (1989) 1.12
Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells. Oncogene (1997) 1.12
Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis (1992) 1.11
A physiological model for simulation of benzene metabolism by rats and mice. Toxicol Appl Pharmacol (1989) 1.08
Aryl 4-monooxygenase and cytochrome P-450 in the aorta: possible role in atherosclerosis. Proc Natl Acad Sci U S A (1976) 1.06
Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol (1998) 1.05
Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions. J Toxicol Environ Health (1981) 1.05
Species differences in the disposition of inhaled butadiene. Toxicol Appl Pharmacol (1986) 1.04
Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells. Mol Cell Biol (2000) 1.02
Effect of fatty acids on the proliferation of concanavalin A-stimulated rat lymph node lymphocytes. Int J Biochem (1991) 1.01
Benzene and phenol metabolism by mouse and rat liver microsomes. Carcinogenesis (1993) 0.99
Molecular analysis of lacI mutants from bone marrow of B6C3F1 transgenic mice following inhalation exposure to 1,3-butadiene. Carcinogenesis (1994) 0.97
Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients. J Biochem Mol Toxicol (2000) 0.96
Pulmonary toxicity of inhaled diesel exhaust and carbon black in chronically exposed rats. Part I: Neoplastic and nonneoplastic lung lesions. Res Rep Health Eff Inst (1994) 0.96
Formation of beta-hydroxyisovalerate by an alpha-ketoisocaproate oxygenase in human liver. Metabolism (1983) 0.95
The mechanism of alpha-ketoisocaproate oxygenase. Formation of beta-hydroxyisovalerate from alpha-ketoisocaproate. J Biol Chem (1982) 0.95
A reverse isotope dilution method for determining benzene and metabolites in tissues. J Anal Toxicol (1988) 0.95
Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus. Arch Virol (2010) 0.94
The fate of isoprene inhaled by rats: comparison to butadiene. Toxicol Appl Pharmacol (1987) 0.94
Benzene metabolism by human liver microsomes in relation to cytochrome P450 2E1 activity. Carcinogenesis (1994) 0.94
Subcellular distribution and partial characterization of an alpha-ketoisocaproate oxidase of rat liver: formation of beta-hydroxyisovaleric acid. Arch Biochem Biophys (1981) 0.92
Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis (1995) 0.92
Morphologic and biochemical studies of a nitrobenzene-induced encephalopathy in rats. Neurotoxicology (1985) 0.92
Toxicokinetics of inhaled 1,3-butadiene in monkeys: comparison to toxicokinetics in rats and mice. Toxicol Appl Pharmacol (1991) 0.92
Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression. Mol Carcinog (1992) 0.91
Sites and mechanisms for uptake of gases and vapors in the respiratory tract. Toxicology (2001) 0.91
Correlated abnormalities of transforming growth factor-beta 1 response and p53 expression in thyroid epithelial cell transformation. Mol Cell Endocrinol (1991) 0.90
Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice. Toxicology (1996) 0.90
Differential white cell count after two bouts of downhill running. Int J Sports Med (1998) 0.88
Does telomere shortening drive selection for p53 mutation in human cancer? Mol Carcinog (1995) 0.87
Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured human fetal aortic smooth muscle cells. Life Sci (1979) 0.86
S phase cell-cycle arrest following DNA damage is independent of the p53/p21(WAF1) signalling pathway. Oncogene (1996) 0.86
Purification and characterization of an alpha-ketoisocaproate oxygenase of rat liver. J Biol Chem (1982) 0.85
Transcriptional down-regulation of the retinoblastoma protein is associated with differentiation and apoptosis in human colorectal epithelial cells. Br J Cancer (2001) 0.85
A toxikinetic model for simulation of benzene metabolism. Exp Pathol (1989) 0.84
Species differences in the metabolism and disposition of inhaled 1,3-butadiene and isoprene. Environ Health Perspect (1990) 0.84
Comparison of 3 methods of exposing rats to cigarette smoke. Exp Pathol (1989) 0.84
Effects of adsorption of benzo[a]pyrene onto carbon black particles on levels of DNA adducts in lungs of rats exposed by inhalation. Toxicol Appl Pharmacol (1989) 0.84
Glutathione conjugation of 1,2:3,4- diepoxybutane in human liver and rat and mouse liver and lung in vitro. Toxicol Appl Pharmacol (1996) 0.84
The retention of polycyclic aromatic hydrocarbons in the bronchial airways and in the alveolar region--a theoretical comparison. Toxicol Appl Pharmacol (1991) 0.84
Formation of hydrogen peroxide and N-hydroxylated amines catalyzed by pulmonary flavin-containing monooxygenases in the presence of primary alkylamines. Arch Biochem Biophys (1986) 0.83
Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in chicken aortas: monooxygenation, bioactivation to mutagens, and covalent binding to DNA in vitro. Toxicol Appl Pharmacol (1980) 0.83
Differences in the pathways for metabolism of benzene in rats and mice simulated by a physiological model. Environ Health Perspect (1989) 0.83
A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B6C3F1 mice, F344 rats, and humans. Toxicol Appl Pharmacol (1997) 0.83
Sites for uptake of inhaled vapors in beagle dogs. Toxicol Appl Pharmacol (1991) 0.83
Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis (1994) 0.83
Effect of vapor concentration on the disposition of inhaled 2,3-dichloropropene in Fischer-344 rats. Fundam Appl Toxicol (1985) 0.83
The fate of inhaled azodicarbonamide in rats. Fundam Appl Toxicol (1987) 0.83
Effects of a thirteen-week inhalation exposure to ethyl tertiary butyl ether on fischer-344 rats and CD-1 mice. Toxicol Sci (1999) 0.82
Quantitative and qualitative differences in the metabolism of 14C-1,3-butadiene in rats and mice: relevance to cancer susceptibility. Toxicol Sci (1999) 0.82
Uptake and excretion of [14C]methyl bromide as influenced by exposure concentration. Toxicol Appl Pharmacol (1985) 0.81
Characterization of hemoglobin adduct formation in mice and rats after administration of [14C]butadiene or [14C]isoprene. Toxicol Appl Pharmacol (1989) 0.81
Carboxylesterases in the respiratory tracts of rabbits, rats and Syrian hamsters. Toxicol Lett (1987) 0.81
Critical issues in benzene toxicity and metabolism: the effect of interactions with other organic chemicals on risk assessment. Environ Health Perspect (1994) 0.81
The role of hydrolysis in the detoxification of 1,2:3,4-diepoxybutane by human, rat, and mouse liver and lung in vitro. Toxicol Appl Pharmacol (1996) 0.81
Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene. Chem Res Toxicol (1996) 0.81
Identification of distinct hepatic and pulmonary forms of microsomal flavin-containing monooxygenase in the mouse and rabbit. Biochem Biophys Res Commun (1985) 0.80
Suppression of transformation and immortality in human/Chinese hamster fibroblast hybrids--a model for suppressor gene isolation. Int J Cancer (1989) 0.79
In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data. Carcinogenesis (1994) 0.79
Effect of inhibitors of eicosanoid synthesis upon lymphocyte proliferation. Biochem Soc Trans (1991) 0.79
Determination of mutagenicity in tissues of transgenic mice following exposure to 1,3-butadiene and N-ethyl-N-nitrosourea. Toxicol Appl Pharmacol (1992) 0.79
Metabolism of 1-[14C]nitropyrene in isolated perfused rat livers. Toxicol Appl Pharmacol (1984) 0.79
Evaluation of 1,3-butadiene, isoprene and chloroprene health risks. Chem Biol Interact (2001) 0.79
Metabolic interactions of 1,3-butadiene and styrene in male B6C3F1 mice. Toxicol Appl Pharmacol (1996) 0.78
Fatty acid inhibition of concanavalin A-stimulated lymphocyte proliferation. Biochem Soc Trans (1989) 0.78
Hepatic and pulmonary glutathione conjugation of 1,2:3,4-diepoxybutane in human, rat, and mouse in vitro. Toxicology (1996) 0.78
Induction of cell death by stimulation of protein kinase C in human epithelial cells expressing a mutant ras oncogene: a potential therapeutic target. Br J Cancer (1998) 0.78
Biliary excretion and enterohepatic circulation of 1-nitropyrene metabolites in Fischer-344 rats. Biochem Pharmacol (1985) 0.78
Disposition of inhaled isobutene in F344/N rats. Toxicol Appl Pharmacol (1993) 0.78
Biochemical and morphologic responses of rat nasal epithelia to hyperoxia. Fundam Appl Toxicol (1991) 0.78
High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Toxicol Appl Pharmacol (1995) 0.77
Kinetics, activation, and induction of aortic mono-oxygenases--biotransformation of benzo[a]pyrene. Biochem Pharmacol (1979) 0.77
Metabolism of benzo[a]pyrene on the nasal mucosa of Syrian hamsters: comparison to metabolism by other extrahepatic tissues and possible role of nasally produced metabolites in carcinogenesis. J Natl Cancer Inst (1985) 0.77
Characterization of the purified microsomal FAD-containing monooxygenase from mouse and pig liver. Chem Biol Interact (1984) 0.77
Sex-dependent metabolism and biliary excretion of [2,4-14C] dinitrotoluene in isolated perfused rat livers. J Pharmacol Exp Ther (1981) 0.77
Fatty acid inhibition of lipopolysaccharide-stimulated B lymphocyte proliferation. Biochem Soc Trans (1990) 0.77
Conditional immortalization of human thyroid epithelial cells: a tool for analysis of oncogene action. Mol Cell Biol (1990) 0.77
Dose concepts for inhaled vapors and gases. Toxicol Appl Pharmacol (1990) 0.77
Pharmacokinetics of inhaled [14C]methanol and methanol-derived [14C]formate in normal and folate-deficient cynomolgus monkeys. Toxicol Appl Pharmacol (1994) 0.77
Purification of the flavin-containing monooxygenase from mouse and pig liver microsomes. Int J Biochem (1984) 0.77
An amphotropic retroviral vector expressing a mutant gsp oncogene: effects on human thyroid cells in vitro. J Clin Endocrinol Metab (1997) 0.77
Lung retention of diesel soot and associated organic compounds. Dev Toxicol Environ Sci (1986) 0.77
Physiologically based pharmacokinetic modeling of 1,3-butadiene, 1,2-epoxy-3-butene, and 1,2:3,4-diepoxybutane toxicokinetics in mice and rats. Carcinogenesis (1997) 0.77
Particle-associated polycyclic aromatic hydrocarbons--a reappraisal of their possible role in pulmonary carcinogenesis. Toxicol Appl Pharmacol (1991) 0.76
Induction of hepatic and testicular lesions in Fischer-344 rats by single oral doses of nitrobenzene. Fundam Appl Toxicol (1983) 0.76
Use of transgenic mice for assessing the mutagenicity of 1,3-butadiene in vivo. IARC Sci Publ (1993) 0.76
A physiologically based model of 1-nitropyrene metabolism after inhalation or ingestion. Health Phys (1989) 0.76
Biomonitoring of 1,3-butadiene and related compounds. Environ Health Perspect (1996) 0.76
Purification and assay of alpha-ketoisocaproate dioxygenase from rat liver. Methods Enzymol (1988) 0.76
Benzene dosimetry in experimental animals: relevance for risk assessment. Prog Clin Biol Res (1992) 0.76
Deposition, metabolism, and excretion of 1-[14C]nitropyrene and 1-[14C]nitropyrene coated on diesel exhaust particles as influenced by exposure concentration. Toxicol Appl Pharmacol (1986) 0.76
Mutagenicity and mutational spectra of 1,3-butadiene in the bone marrow of B6C3F1 lacI transgenic mice. Toxicology (1996) 0.76